Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1972 1
1976 3
1977 3
1978 7
1979 2
1980 3
1981 1
1982 2
1983 3
1984 3
1985 2
1986 2
1987 5
1988 3
1989 3
1990 7
1991 2
1992 3
1993 2
1994 10
1995 4
1996 5
1997 7
1998 4
1999 12
2000 17
2001 22
2002 21
2003 37
2004 30
2005 49
2006 57
2007 52
2008 67
2009 62
2010 97
2011 94
2012 98
2013 87
2014 83
2015 102
2016 120
2017 102
2018 91
2019 115
2020 139
2021 187
2022 180
2023 189
2024 227
2025 231

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,374 results

Results by year

Filters applied: . Clear all
Page 1
Central serous chorioretinopathy: An evidence-based treatment guideline.
Feenstra HMA, van Dijk EHC, Cheung CMG, Ohno-Matsui K, Lai TYY, Koizumi H, Larsen M, Querques G, Downes SM, Yzer S, Breazzano MP, Subhi Y, Tadayoni R, Priglinger SG, Pauleikhoff LJB, Lange CAK, Loewenstein A, Diederen RMH, Schlingemann RO, Hoyng CB, Chhablani JK, Holz FG, Sivaprasad S, Lotery AJ, Yannuzzi LA, Freund KB, Boon CJF. Feenstra HMA, et al. Among authors: lai tyy. Prog Retin Eye Res. 2024 Jul;101:101236. doi: 10.1016/j.preteyeres.2024.101236. Epub 2024 Feb 1. Prog Retin Eye Res. 2024. PMID: 38301969 Free article. Review.
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Heier JS, Khanani AM, Quezada Ruiz C, Basu K, Ferrone PJ, Brittain C, Figueroa MS, Lin H, Holz FG, Patel V, Lai TYY, Silverman D, Regillo C, Swaminathan B, Viola F, Cheung CMG, Wong TY; TENAYA and LUCERNE Investigators. Heier JS, et al. Among authors: lai tyy. Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085502 Clinical Trial.
Macular neovascularization.
Sheth JU, Stewart MW, Narayanan R, Anantharaman G, Chandran K, Lai TYY, Chakravarthy U, Das T. Sheth JU, et al. Among authors: lai tyy. Surv Ophthalmol. 2025 Jul-Aug;70(4):653-675. doi: 10.1016/j.survophthal.2024.08.003. Epub 2024 Aug 31. Surv Ophthalmol. 2025. PMID: 39222802 Review.
Pachychoroid disease: review and update.
Cheung CMG, Dansingani KK, Koizumi H, Lai TYY, Sivaprasad S, Boon CJF, Van Dijk EHC, Chhablani J, Lee WK, Freund KB. Cheung CMG, et al. Among authors: lai tyy. Eye (Lond). 2025 Apr;39(5):819-834. doi: 10.1038/s41433-024-03253-4. Epub 2024 Aug 3. Eye (Lond). 2025. PMID: 39095470 Free PMC article. Review.
Cross-species single-cell spatial transcriptomic atlases of the cerebellar cortex.
Hao S, Zhu X, Huang Z, Yang Q, Liu H, Wu Y, Zhan Y, Dong Y, Li C, Wang H, Haasdijk E, Wu Z, Li S, Yan H, Zhu L, Guo S, Wang Z, Ye A, Lin Y, Cui L, Tan X, Liu H, Wang M, Chen J, Zhong Y, Du W, Wang G, Lai T, Cao M, Yang T, Xu Y, Li L, Yu Q, Zhuang Z, Xia Y, Lei Y, An Y, Cheng M, Zhao Y, Han L, Yuan Y, Song X, Song Y, Gu L, Liu C, Lin X, Wang R, Wang Z, Wang Y, Li S, Li H, Song J, Chen M, Zhou W, Yuan N, Sun S, Wang S, Chen Y, Zheng M, Fang J, Zhang R, Zhang S, Chai Q, Liu J, Wei W, He J, Zhou H, Sun Y, Liu Z, Liu C, Yao J, Liang Z, Xu X, Poo M, Li C, De Zeeuw CI, Shen Z, Liu Z, Liu L, Liu S, Sun Y, Liu C. Hao S, et al. Among authors: lai t. Science. 2024 Sep 27;385(6716):eado3927. doi: 10.1126/science.ado3927. Epub 2024 Sep 27. Science. 2024. PMID: 39325889
A spatiotemporal atlas of cholestatic injury and repair in mice.
Wu B, Shentu X, Nan H, Guo P, Hao S, Xu J, Shangguan S, Cui L, Cen J, Deng Q, Wu Y, Liu C, Song Y, Lin X, Wang Z, Yuan Y, Ma W, Li R, Li Y, Qian Q, Du W, Lai T, Yang T, Liu C, Ma X, Chen A, Xu X, Lai Y, Liu L, Esteban MA, Hui L. Wu B, et al. Among authors: lai t. Nat Genet. 2024 May;56(5):938-952. doi: 10.1038/s41588-024-01687-w. Epub 2024 Apr 16. Nat Genet. 2024. PMID: 38627596
Reply.
Teo KYC, Kokame G, Sadda SR, Fujimoto S, Gomi F, Kim JE, Cheng MFS, Corradetti G, Amornpetchsathaporn A, Chainakul M, Lee WK, Lai TYY, Ruamviboonsuk P, Cheung CMG. Teo KYC, et al. Among authors: lai tyy. Ophthalmol Retina. 2023 Jul;7(7):e10-e11. doi: 10.1016/j.oret.2023.03.013. Epub 2023 Apr 20. Ophthalmol Retina. 2023. PMID: 37086256 No abstract available.
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.
Tadayoni R, Paris LP, Danzig CJ, Abreu F, Khanani AM, Brittain C, Lai TYY, Haskova Z, Sakamoto T, Kotecha A, Schlottmann PG, Liu Y, Seres A, Retiere AC, Willis JR, Yoon YH; BALATON and COMINO Investigators. Tadayoni R, et al. Among authors: lai tyy. Ophthalmology. 2024 Aug;131(8):950-960. doi: 10.1016/j.ophtha.2024.01.029. Epub 2024 Jan 26. Ophthalmology. 2024. PMID: 38280653 Free article. Clinical Trial.
Single cell multi-omics reveal intra-cell-line heterogeneity across human cancer cell lines.
Zhu Q, Zhao X, Zhang Y, Li Y, Liu S, Han J, Sun Z, Wang C, Deng D, Wang S, Tang Y, Huang Y, Jiang S, Tian C, Chen X, Yuan Y, Li Z, Yang T, Lai T, Liu Y, Yang W, Zou X, Zhang M, Cui H, Liu C, Jin X, Hu Y, Chen A, Xu X, Li G, Hou Y, Liu L, Liu S, Fang L, Chen W, Wu L. Zhu Q, et al. Among authors: lai t. Nat Commun. 2023 Dec 9;14(1):8170. doi: 10.1038/s41467-023-43991-9. Nat Commun. 2023. PMID: 38071219 Free PMC article.
2,374 results